Skip to main content
Clinical Trials/NCT02442401
NCT02442401CompletedPhase 1

Role of Negative Pressure Wound Therapy in Latissimus Dorsi Flap Donor Site Seroma Prevention

Chulalongkorn University0 sites40 target enrollmentStarted: January 1, 2009Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
40
Primary Endpoint
Incidence of seroma

Study Overview

Brief Summary

The use of NPWT as a post-operative dressing significantly reduces the incidence of seroma formation after harvesting LD flap.

Detailed Description

NPWT was left in place on donor site with constant pressure between -125 and -80 mmHg to reduce seroma formation

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
20 Years to 60 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age between 20-60 years Underwent breast reconstruction with LD Flap

Exclusion Criteria

  • •Locally advanced cancer

Arms & Interventions

NPWT group

Experimental

Negative pressure wound therapy was used to prevent donor site seroma formation

Intervention: The negative pressure wound therapy (Device)

Control group

No Intervention

Conventional method was used to the donor site

Outcomes

Primary Outcomes

Incidence of seroma

Time Frame: 3 months

Secondary Outcomes

  • Frequency of Aspiration(3 months)
  • Aspirated Volume(3 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Apichai Angspatt

Apichai Angspatt

Chulalongkorn University

Similar Trials